Results 161 to 170 of about 99,855 (366)

Hard-Attention Gates with Gradient Routing for Endoscopic Image Computing [PDF]

open access: yesIn Proceedings of the 27th International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI 2024), 2024
To address overfitting and enhance model generalization in gastroenterological polyp size assessment, our study introduces Feature-Selection Gates (FSG) or Hard-Attention Gates (HAG) alongside Gradient Routing (GR) for dynamic feature selection.
arxiv  

Novel insect-based child nutrition: the position of the nutritional committee of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP). [PDF]

open access: yesItal J Pediatr, 2023
Norsa L   +8 more
europepmc   +1 more source

Clinical Outcomes of Intensity Modulated Proton Therapy for Salivary Gland Carcinoma: High Local Control and Quality of Life Preservation

open access: yesHead &Neck, EarlyView.
ABSTRACT Background In recent years, particle therapy has shown promise as a local treatment for salivary gland carcinoma (SGC); however, its efficacy and safety remain unclear. This study aimed to evaluate the clinical outcomes of intensity‐modulated proton therapy (IMPT) for SGC.
Gaku Takano   +16 more
wiley   +1 more source

Equity and Inclusion in Pediatric Gastroenterology Telehealth: A Study of Demographic, Socioeconomic, and Digital Disparities. [PDF]

open access: yesJ Pediatr Gastroenterol Nutr, 2023
Mougey EB   +10 more
europepmc   +1 more source

Pediatric Gastroenterology

open access: yesGastroenterology, 1970
Mervin Silverberg, Murray Davidson
openaire   +3 more sources

Upper Gastrointestinal Involvement in Pediatric Crohn's Disease Reply [PDF]

open access: yes, 2009
David C. Wilson   +12 more
core   +1 more source

Conversion Surgery After Administration of a TRK Inhibitor for Unresectable Parotid Gland Secretory Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The NTRK fusion gene is detected in most salivary gland secretory carcinomas. While tropomyosin receptor kinase (TRK) inhibitors are used for various solid tumors with the fusion gene, there are no reports regarding TRK inhibitor use for unresectable parotid gland carcinomas that subsequently shrink and become resectable.
Arisa Nagano   +11 more
wiley   +1 more source

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE

open access: yesПедиатрическая фармакология, 2009
.
E.N. Fedulova   +5 more
doaj   +2 more sources

Abridging the 22‐Item Sino‐Nasal Outcome Test (SNOT‐22) in People With Cystic Fibrosis: Limiting Survey Burden

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Haidee Chen   +36 more
wiley   +1 more source

Home - About - Disclaimer - Privacy